Brief: NexImmune Reports Q4 And Full Year 2021 Financial Results
09/03/2022 22:36
March 9 (Reuters) - Neximmune Inc NEXI.O :
* NEXIMMUNE REPORTS FOURTH QUARTER AND FULL YEAR 2021
FINANCIAL
RESULTS AND PROVIDES BUSINESS UPDATES
* NEXIMMUNE INC - EXPECTS EXISTING CASH, EQUIVALENTS,
MARKETABLE
SECURITIES WILL ENABLE CO TO FUND OPERATING, CAPEX NEEDS INTO Q2
OF 2023
* NEXIMMUNE INC QTRLY GAAP LOSS PER SHARE OF $0.68
Source text for Eikon: ID:nGNXbJ8QFm
Further company coverage: NEXI.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Neximmune
See all newsBrief: Neximmune Appointed Albert Marchio As Interim CFO
Brief: NexImmune and Agents Agreed To Terminate Sales Agreement & ATM Program dated June 2022
Brief: NexImmune Says Co Expects Existing Cash And Cash Equivalents Will Be Sufficient To Meet Its Anticipated Cash Requirements Through Mid-February 2024
Brief: Neximmune Gets Notice From Listing Qualifications Department Of Nasdaq
Brief: NexImmune Announces Presentations at The Society for Immunotherapy of Cancer’s 38th Annual Meeting